HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Electrical cardioversion after quinidine administration].

Abstract
The aim of the present study was to investigate the influence of quinidine on the effectiveness of electrical cardioversion (CV) for the reversion of supraventricular arrhythmias, the amount of electrical energy necessary for the CV and the possible complications of electrical CV. Initially, 100 CV procedures were allocated to the control group (patients free from the action of any antiarrhythmic drug), and 50 CV to the quinidine group. Quinidine was given as dihydroquinidine C1H at a dose of 500 mg/12 hours since the day before CV. In the last group, 6 (12%) patients reverted to normal sinus rhythm before electrical CV. At the time of electrical CV (100 procedures in the control group and 44 in the quinidine group), the patients who received quinidine required a lower amount of electrical energy, and showed a lower incidence of atrial premature beats as compared with the control group (11.3% versus 28%, p less than 0.05). A similar proportion of patients reverted to sinus rhythm in both groups. We conclude that the administration of quinidine before electrical CV has the following advantages: 1) 12% of patients reverted to normal sinus rhythm before electrical CV; 2) quinidine reduced the amount of electrical energy necessary for the CV, and 3) quinidine reduced the incidence of atrial premature beats after electrical CV. On the other hand, quinidine had no influence on the incidence of ventricular arrhythmias after electrical CV.
AuthorsJ Sagristá Sauleda, G Permanyer Miralda, J Soler Soler
JournalRevista espanola de cardiologia (Rev Esp Cardiol) Vol. 43 Issue 9 Pg. 604-9 (Nov 1990) ISSN: 0300-8932 [Print] Spain
Vernacular TitleCardioversión eléctrica bajo la acción de la quinidina.
PMID2099522 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Quinidine
Topics
  • Adult
  • Aged
  • Electric Countershock (adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Quinidine (pharmacology)
  • Tachycardia, Supraventricular (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: